Related Experiment Video

Updated: Aug 13, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1): potential basis for a

Farid Moinfar1, Margit Gogg-Kamerer, Andrea Sommersacher

  • 1Institute of Pathology, Medical University Graz, Graz, Austria. farid.moinfar@meduni-graz.at

The American Journal of Surgical Pathology
|March 16, 2005
PubMed

Insights

Endometrial stromal sarcomas commonly express epidermal growth factor receptor (EGFR) (HER-1). This finding in rare uterine tumors suggests new targeted therapy options, like EGFR inhibitors, for patients.

Area of Science:

  • Gynecologic Oncology
  • Cancer Biology
  • Molecular Pathology

Background:

  • Endometrial stromal sarcomas are rare uterine malignancies.
  • Epidermal growth factor receptor (EGFR) family expressions are not well-characterized in these tumors.

Purpose of the Study:

  • To investigate the expression of EGFR (HER-1), HER-2, HER-3, and HER-4 in endometrial stromal sarcomas.
  • To explore potential therapeutic targets for this rare cancer.

Main Methods:

  • Immunohistochemical analysis of 23 endometrial sarcoma cases (20 low-grade, 3 undifferentiated).
  • Detection of EGFR (HER-1), HER-2, HER-3, and HER-4 protein expression.

Main Results:

  • EGFR (HER-1) was expressed in 74% (17/23) of cases.
  • EGFR (HER-1) was positive in all undifferentiated sarcomas and 70% of low-grade sarcomas.
  • No expression of HER-2, HER-3, or HER-4 was detected.

Conclusions:

  • This study is the first to demonstrate frequent EGFR (HER-1) expression in endometrial stromal sarcomas.
  • EGFR (HER-1) represents a potential therapeutic target for endometrial stromal sarcomas.
  • Targeted therapies like EGFR inhibitors (cetuximab, gefitinib) may offer new treatment strategies.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...